Lab weathers storms, not concerns?

A high-security pathogen lab in Galveston, Texas, survived the hurricane that hit the region last month, but is now the focus of safety concerns plaguing biosafety research of late. Galveston is an island often hit by hurricanes. Ike, which hit in September, caused more than $700 million in damage to the University of Texas facilities there, about $18 million of that to research labs, Nature linkurl:reported.;http://www.nature.com/news/2008/081022/full/4551012a.html But the pathogen lab escaped

Written byAlla Katsnelson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
A high-security pathogen lab in Galveston, Texas, survived the hurricane that hit the region last month, but is now the focus of safety concerns plaguing biosafety research of late. Galveston is an island often hit by hurricanes. Ike, which hit in September, caused more than $700 million in damage to the University of Texas facilities there, about $18 million of that to research labs, Nature linkurl:reported.;http://www.nature.com/news/2008/081022/full/4551012a.html But the pathogen lab escaped unscathed. "The entire island can wash away and this is still going to be there," the lab's deputy director, James W. LeDuc, linkurl:told;http://www.nytimes.com/2008/10/29/us/29lab.html?_r=1&oref=slogin the New York Times. Still, some say that locating a lab working with dangerous pathogens such as linkurl:Ebola;http://www.the-scientist.com/blog/display/54827/ and Marburg virus in a geographical area so vulnerable to storm damage is risky. "As destructive as it was, Hurricaine Ike was only a Category 2 storm," Ken Kramer, director of the Sierra Club's linkurl:Lone Star Chapter;http://lonestar.sierraclub.org/ told the Times. "A more powerful storm would pose an even greater threat of a biohazard release." The lab is a kind of sister institution to a similar but much more contentious project in linkurl:Boston,;http://www.the-scientist.com/blog/display/55087/ which has been stalled over safety concerns. Both were pushed by President George W. Bush's administration in the wake of the terrorist attacks on September 11, 2001. Galveston has run a small-scale BSL-4 lab since 2004, but a state-of-the-art $174 million building housing an expanded facility is set to open in November. Both safely survived the storm. The new building, 30 feet above sea level, was constructed to withstand the area's wild weather, from 140-mile winds to power outages. Extensive air filters, waste disposal protocols, and plans for stopping research and destroying some live viruses 24 hours before a storm hits should be enough to keep the facilities safe, officials say, though concerns still linger. Galveston is one of the five currently operating BSL-4 labs in the country; two other labs on that list were found to have serious linkurl:security shortfalls;http://www.the-scientist.com/blog/display/55093/ earlier this month. Four more BSL-4 labs, including Boston's biolab, are now in various stages of planning or construction. Officials are set to decide the final location for one of them, the National Bio and Agro-Defense Facility, by the end of this year.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies